文献速递妇科

子宫腺肌病与子宫内膜癌相关:可能与病理、免疫组化及分子特征的相关性

Adenomyosis associated with endometrial cancer: Possible correlation with pathological, immunohistochemical and molecular characteristics.
PubMed 文献 · Gynecol Oncol · 2025-03-06

这项回顾性队列研究分析172例子宫内膜癌手术分期患者,37.2%合并子宫腺肌病。合并腺肌病者较年轻、绝经后比例低,FIGO分期≥IB期、深肌层浸润、淋巴血管间隙浸润及宫外扩散比例显著更低;多因素分析显示腺肌病为FIGO分期≥IB期的独立保护因素。免疫组化及分子特征无显著差异,腺肌病组KRAS突变有升高趋势。

要点

  • 子宫内膜癌患者中37.2%合并子宫腺肌病,该组患者更年轻且绝经后比例更低。
  • 合并腺肌病者FIGO分期≥IB期、深肌层浸润、淋巴血管间隙浸润及宫外扩散比例显著更低。
  • 多因素分析显示腺肌病为FIGO分期≥IB期的独立保护因素。

核心结论

  • 子宫腺肌病与较低的FIGO分期≥IB期、深肌层浸润、淋巴血管间隙浸润及宫外扩散发生率相关。
  • 作者认为子宫肌层微环境的结构改变可能限制肿瘤侵袭和扩散,需进一步研究。

研究设计与样本

  • 回顾性队列研究,纳入172例接受手术分期的子宫内膜癌患者,按是否合并子宫腺肌病分为两组。
  • 主要终点为FIGO分期≥IB期的发生率;次要终点包括肿瘤组织学类型、分级、淋巴血管间隙浸润、免疫组化标志物及分子改变。
  • 采用逻辑回归分析不良病理特征的独立预测因素。

主要发现

  • 37.2%的子宫内膜癌患者合并子宫腺肌病。
  • 合并腺肌病者更年轻、绝经后比例更低,FIGO分期≥IB期、深肌层浸润、淋巴血管间隙浸润及宫外扩散发生率显著更低。
  • 多因素分析证实子宫腺肌病为FIGO分期≥IB期的独立保护因素。
  • 免疫组化及分子特征无显著差异,但腺肌病组KRAS突变有升高趋势。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND/OBJECTIVE: Adenomyosis is a benign uterine disorder characterized by an inflammatory and hyperestrogenic state. Its association with endometrial cancer (EC) remains controversial. This study aimed to investigate the correlation between adenomyosis and the pathological, immunohistochemical (IHC), and molecular features of EC. METHODS: This retrospective cohort study analyzed 172 patients with EC who underwent surgical staging. Patients were stratified into two groups based on the presence of adenomyosis. The primary endpoint was the prevalence of FIGO stage ≥IB disease. Secondary endpoints included tumor histotype, grade, lymphovascular invasion, IHC markers, and molecular alterations. Logistic regression was performed to identify independent predictors of adverse pathological features. RESULTS: Adenomyosis was identified in 37.2 % of EC patients. These patients were younger, less likely to be postmenopausal, and exhibited significantly lower rates of FIGO stage ≥IB disease, deep myometrial invasion, lymphovascular invasion, and extrauterine spread. Multivariate analysis confirmed adenomyosis as an independent protective factor against FIGO stage ≥IB disease. This protective effect could be attributed to the altered myometrial microenvironment in adenomyosis, characterized by inflammation, smooth muscle hyperplasia, and fibrosis, which appears to limit tumor invasiveness. No significant differences were observed in IHC or molecular profiles, although a trend toward higher prevalence of KRAS mutations was observed in patients with adenomyosis. CONCLUSION: Adenomyosis was associated with a lower prevalence of FIGO stage ≥IB disease, deep myometrial invasion, lymphovascular invasion, and extrauterine spread. These findings suggest that structural changes in the myometrial microenvironment may play a role in limiting tumor invasiveness and spread, warranting further investigation.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. La Torre F, Hurni Y, Farsi E, et al. Adenomyosis associated with endometrial cancer: Possible correlation with pathological, immunohistochemical and molecular characteristics. Gynecol Oncol. 2025. PMID: 40054046. doi:10.1016/j.ygyno.2025.02.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。